Cite
Manik AH, Malakar D, Noor-E-Alam SM, et al. Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure. J Family Med Prim Care. 2021;10(6):2376-2380doi: 10.4103/jfmpc.jfmpc_2300_20.
Manik, A. H., Malakar, D., Noor-E-Alam, S. M., Mahtab, M. A., Das, D. C., Mamun, A. A., Khan, S., Akbar, M. F., Rahman, Z., & Rahman, S. (2021). Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure. Journal of family medicine and primary care, 10(6), 2376-2380. https://doi.org/10.4103/jfmpc.jfmpc_2300_20
Manik, Abul H, et al. "Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure." Journal of family medicine and primary care vol. 10,6 (2021): 2376-2380. doi: https://doi.org/10.4103/jfmpc.jfmpc_2300_20
Manik AH, Malakar D, Noor-E-Alam SM, Mahtab MA, Das DC, Mamun AA, Khan S, Akbar MF, Rahman Z, Rahman S. Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure. J Family Med Prim Care. 2021 Jun;10(6):2376-2380. doi: 10.4103/jfmpc.jfmpc_2300_20. Epub 2021 Jul 02. PMID: 34322441; PMCID: PMC8284233.
Copy
Download .nbib